Abstract
Figure 2. Effect of (A) Lorcaserin and (B) Placebo on Weight Loss at 1 Year in Patients With Baseline BMI ≥40 kg/m Figure 3. Effect of (A) Lorcaserin and (B) Placebo on Weight Loss at 1 Year in Patients With Baseline BMI 35–39.9 kg/m T-P 3139 Cost Implication of Using Lorcaserin in Weight Management Prior to Bariatric Surgery Zhixiao Wang, Xuan Li, Russell Knoth, Ken Fujioka Eisai Inc., Woodcliff Lake, NJ, USA; Department of Diabetes and Endocrinology, Scripps Clinic, La Jolla, CA, USA
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call